View Day Schedule

Wednesday, November 15, 2023 Print Current Day:

SESSION 23 SCHEDULE
Wednesday SESSION 23: GENERALITIES IN THE ENDOVASCULAR AND OPEN TREATMENT OF LOWER EXTREMITY OCCLUSIVE DISEASE AND CLTI Location: Grand Ballroom East, 3rd Floor Moderators:TBD
x
6:40 AM - 6:45 AM	How Do Prior Endovascular Interventions Affect Future Lower Extremity Bypass Outcomes For CLTI: Why Do The Results Of The BEST-CLI Trial Make This More Important
	Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS Location: Grand Ballroom East, 3rd Floor
6:46 AM - 6:51 AM	Do Diabetic Patients With CLTI And Extensive Foot Necrosis Have Time For An Endovascular First Strategy: Primary Open Bypass Is Better Treatment In This Setting
	Presenter(s):Katariina M. Noronen, MD, PhD Location: Grand Ballroom East, 3rd Floor
6:52 AM - 6:57 AM	Presenting Symptoms Of Lower Extremity Occlusive Disease And Intermittent Claudication Are Different In Women Than In Men: Why Is This Important
	Presenter(s):Linda M. Harris, MD Location: Grand Ballroom East, 3rd Floor
6:58 AM - 7:03 AM	Selective Coronary Revascularization Based On Preop CT Fractional Flow Reserve (FFRCT) Improves 3-Year Survival Of CLTI Patients After Lower Extremity Revascularization (Endo And Open): When Should The Coronary Revascularization Be Performed – Before Or After The Lower Extremity Procedure: Are There Other Precautions – Value Of Troponin Testing
	Presenter(s):Christopher K. Zarins, MD / Dainis K. Krievins, MD Location: Grand Ballroom East, 3rd Floor
7:04 AM - 7:09 AM	Why Does Medial Artery Calcification (MAC) Lead To Small Artery disease (SAD): A Computational Based Analysis Of Lower Limb Blood Flow Reveals That Increasing Vascular Stiffness May Be Causative: Can Anything Be Done About It
	Presenter(s):Roberto Ferraresi, MD Location: Grand Ballroom East, 3rd Floor
OPTIMAL TECHNIQUES FOR VESSEL PREP FOR ENDOVASCULAR TREATMENTS
7:10 AM - 7:15 AM	Optimal Different Techniques Of Vessel Prep For Plain Old Balloon Angioplasty (POBA), Drug Coated Balloon (DCB) Treatment And Drug Eluting Stent (DES) Treatment
	Presenter(s):Fabrizio Fanelli, MD, EBIR Location: Grand Ballroom East, 3rd Floor
7:16 AM - 7:21 AM	Technical Tips For Vessel Prep For DCBs And DESs: It Is Different And Not Simple: Is Vessel Prep Currently Overrated
	Presenter(s):Erwin Blessing, MD Location: Grand Ballroom East, 3rd Floor
7:22 AM - 7:27 AM	New Devices And A New Paradigm For Treating Lower Extremity Arterial Lesions Via A Radial Approach: Can Lesions Below The Knee Be Treated
	Presenter(s):Craig M. Walker, MD Location: Grand Ballroom East, 3rd Floor
7:28 AM - 7:33 AM	What Are The Downsides To Trans-Radial Or Pedal Access
	Presenter(s):Gary M. Ansel, MD Location: Grand Ballroom East, 3rd Floor
TECHNICAL TIPS ON GUIDEWIRE CHOICE AND USAGE
7:34 AM - 7:39 AM	Tips For Treating Difficult BTK/BTA Lesions: How To Get A Guidewire Across A Long Calcified Occlusion, Getting A Resistant Balloon To Go Over The Wire And Tips For Retrograde Access
	Presenter(s):Marco G. Manzi, MD Location: Grand Ballroom East, 3rd Floor
7:40 AM - 7:45 AM	Guidewire Tips For Treating Lesions Below The Ankle (BTA): Sliding, Piercing, Dissecting, Retrograde Maneuvers
	Presenter(s):Roberto Ferraresi, MD Location: Grand Ballroom East, 3rd Floor
7:46 AM - 7:53 AM	Panel Discussion
END OF SESSION 23

SESSION 24 SCHEDULE
Wednesday SESSION 24: NEW DEVELOPMENTS IN ATHERECTOMY, STENTS (UNCOATED, COATED AND BIORESORBABLE) Location: Grand Ballroom East, 3rd Floor Moderators:TBD
x
PROGRESS IN ATHERECTOMY
7:53 AM - 7:58 AM	New Developments In Laser Atherectomy And Lithotripsy: What Progress Has Been Made And Are Their Benefits Proven
	Presenter(s):George L. Adams, MD Location: Grand Ballroom East, 3rd Floor
7:59 AM - 8:04 AM	Which Vascular Specialists Are Performing Tibial Atherectomies And Angioplasties For Intermittent Claudication And Are There Suboptimal Outcomes
	Presenter(s):Caitlin W. Hicks, MD, MS Location: Grand Ballroom East, 3rd Floor
8:05 AM - 8:10 AM	Update On Optical Coherence Tomography (OCT) Guided Intraluminal Crossing And Atherectomy (Pantheris) For Long Total SFA Occlusions: Superiority Over Other Techniques That Use Subintimal Crossing
	Presenter(s):Todd R. Vogel, MD, MPH Location: Grand Ballroom East, 3rd Floor
8:11 AM - 8:16 AM	2-Year Experience With The Rotarex Atherectomy And Thrombectomy System (From BD) For Arterial Occlusive Disease And In Stent Restenosis (ISR): How Does It Work And Advantages
	Presenter(s):Michael K.W. Lichtenberg, MD Location: Grand Ballroom East, 3rd Floor
UPDATE ON THE SUPERA STENT
8:17 AM - 8:23 AM	Update On The Advantages Of The Supera Vasculomimetic (VMI) Stent For Treating Long Complex Fempop Occlusive Lesions: Is There Value To DCB Vessel Prep First
	Presenter(s):Peter C.J. Goverde, MD Location: Grand Ballroom East, 3rd Floor
8:23 AM - 8:28 AM	Update On The Supera Interwoven Stent: When Is It The Best Treatment And How To Optimally Deploy This Unique Stent
	Presenter(s):D. Christopher Metzger, MD / Craig M. Walker, MD Location: Grand Ballroom East, 3rd Floor
DRUG ELUTING STENTS (DESs) FOR BTK LESIONS
8:29 AM - 8:34 AM	Updated Experience With Everolimus And Other Nonabsorbable DESs To Treat Infrapopliteal BTK Lesions – Long And Short - Causing CLTI: What Are The Stents And How Are They Doing
	Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA Location: Grand Ballroom East, 3rd Floor
8:35 AM - 8:40 AM	Update On Bioresorbable Everolimus DESs To Treat BTK Lesions Causing CLTI: Promising Results Up To 5 Years: From The DISAPEAR Registry And A Meta-Analysis Of Other Bioresorbable BTK Stent Results
	Presenter(s):Steven Kum, MD / Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) Location: Grand Ballroom East, 3rd Floor
8:41 AM - 8:46 AM	Progress In And Early Results Of The LIFE-BTK Randomized Controlled Comparison Of Abbott’s Esprit Drug-Eluting Resorbable Stent With Plain Balloon Angioplasty (POBA)
	Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) / Sahil A. Parikh, MD / Brian G. DeRubertis, MD Location: Grand Ballroom East, 3rd Floor
8:47 AM - 8:52 AM	Updated Results With A 3-French Compatible Microstent (From Micro Medical) For Antegrade Or Retrograde Insertion To Treat Tibial Artery Lesions: From The STAND RCT And The HEAL Registry
	Presenter(s):Robert E. Beasley, MD, FSIR, FSCAI / Marco G. Manzi, MD Location: Grand Ballroom East, 3rd Floor
8:53 AM - 9:00 AM	Panel Discussion
END OF SESSION 24

SESSION 25 SCHEDULE
Wednesday SESSION 25: LOWER EXTREMITY TOPICS RELATED TO DRUG COATED BALLOONS (DCBs) AND DRUG ELUTING STENTS (DESs) Location: Grand Ballroom East, 3rd Floor Moderators:TBD
x
9:00 AM - 9:05 AM	Older And More Recent Meta-Analyses Reveal Increased Mortality And Amputation Rates In Patients Receiving Paclitaxel Coated Devices Compared To Uncoated Devices: Are These Increased Rates Still Valid In View Of The Many Recent Studies That Do Not Confirm Them
	Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR Location: Grand Ballroom East, 3rd Floor
9:06 AM - 9:11 AM	Large Population Based German Multicenter Study Of Paclitaxel Coated BTK DCBs And DESs Indicates Decreased Mortality And Amputation Rates Compared To Uncoated Devices
	Presenter(s):Christian A. Behrendt, MD Location: Grand Ballroom East, 3rd Floor
9:12 AM - 9:17 AM	The Final Word On The Safety Of Paclitaxel Coated Balloons And Stents: Putting Together Observation, Randomized Trial And Meta-Analysis Derived Data
	Presenter(s):Eric A. Secemsky, MD, MSc Location: Grand Ballroom East, 3rd Floor
9:18 AM - 9:23 AM	2-Year Results With The Sundance DCB (Surmodics) To Treat BTK Occlusive Lesions: From The Swing Trial
	Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) Location: Grand Ballroom East, 3rd Floor
9:24 AM - 9:29 AM	Update On DCBs For BTK Angioplasty: RCT Comparing A Paclitaxel DCB (Litos From Acotec) Versus A Sirolimus DCB (Magic Touch From Concept Medical): 6-Month Results from the DEBATE BTK DUELL RCT
	Presenter(s):Francesco Liistro, MD Location: Grand Ballroom East, 3rd Floor
9:30 AM - 9:35 AM	Progress With A Sustained Release Sirolimus DCB: Results With The Magic Touch DCB Compared To A Paclitaxel DCB: From The SIRONA Study
	Presenter(s):Thomas Zeller, MD / Andrej Schmidt, MD / Dierk Scheinert, MD / Marianne Brodmann, MD Location: Grand Ballroom East, 3rd Floor
9:36 AM - 9:41 AM	Advential Drug Delivery With The BullFrog Device (From Mercator Medical) And The Spur Device (From ReFlow): How Do They Work And How Will We Know They Improve Results
	Presenter(s):William A. Gray, MD Location: Grand Ballroom East, 3rd Floor
9:42 AM - 9:47 AM	The Light And Darkness Of Fluoropolymer-Based Limus DESs In The Treatment Of Femoropopliteal Lesions
	Presenter(s):Osamu Iida, MD Location: Grand Ballroom East, 3rd Floor
9:48 AM - 9:53 AM	TBD
9:54 AM - 9:59 AM	Are DESs Ever Associated With Aneurysmal Degeneration: Is It Related To The Drug (Paclitaxel Or Limus) Or To The Fluoropolymer Excipient To Which The Drug Is Attached)
	Presenter(s):Osamu Iida, MD Location: Grand Ballroom East, 3rd Floor
10:00 AM - 10:08 AM	Panel Discussion
10:08 AM - 10:18 AM	Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 25

SESSION 26 SCHEDULE
Wednesday SESSION 26: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs) AND DRUG ELUTING STENTS (DESs): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTs) AND BTK LESION TREATMENTS WITH DCBs AND DESs Location: Grand Ballroom East, 3rd Floor Moderators:TBD
x
NEW INFORMATION ON DCBs AND DESs FOR FEMPOP LESIONS: UPDATES ON RCTs
10:18 AM - 10:23 AM	DCB Treatment Of Femoropopliteal Lesions Causing CLTI (From Boston Scientific) Is Cost Effective: Based On A 2-Year Study Of Patients Treated With Ranger DCBs: Advantages Of An .018 Device Often Suitable For Radial Access
	Presenter(s):Ignacio Escotto, MD Location: Grand Ballroom East, 3rd Floor
10:24 AM - 10:29 AM	Stellarex (Philips) DCBs With Low Dose Paclitaxel Is Safe And Has Higher Patency Rates Than POBA With De Novo Or Recurrent Fempop Lesions At 5 Years In The ILLUMENATE US And European RCTs
	Presenter(s):Sean P. Lyden, MD / Marianne Brodmann, MD / Sahil A. Parikh, MD / William A. Gray, MD Location: Grand Ballroom East, 3rd Floor
10:30 AM - 10:35 AM	2-Year Results Of A RCT Comparing SurVeil DCBs (Surmodics) With In.Pact DCBs For Treating Fempop Lesions: From the TRANSCEND Trial
	Presenter(s):Peter A. Schneider, MD Location: Grand Ballroom East, 3rd Floor
10:36 AM - 10:41 AM	New Findings From The DRASTICO Study Comparing DESs To DCBs For Fempop Lesions: 5-Year Results With TASC A/B Lesions Versus TASC C/D Lesions
	Presenter(s):Francesco Liistro, MD Location: Grand Ballroom East, 3rd Floor
10:42 AM - 10:47 AM	Value Of In.Pact DCBs For Long Complex SFA-Pop Lesions Including ISR And CTOs: Technical Tips And Contraindications: From The Global Registry: What Is The Best Endo Treatment For These Lesions
	Presenter(s):Gunnar Tepe, MD / Marianne Brodmann, MD Location: Grand Ballroom East, 3rd Floor
10:48 AM - 10:53 AM	Update On The Randomized Head To Head Comparison Of In.Pact (Medtronic) And Ranger (Boston Scientific) DCBs For Complex SFA Lesions: 3-Year Results Of The COMPARE RCT: Similar Results With Different Paclitaxel Dosages
	Presenter(s):Dierk Scheinert, MD / Sabine Steiner, MD Location: Grand Ballroom East, 3rd Floor
10:54 AM - 10:59 AM	Below The Ankle Endo Interventions In 2023: Techniques, Devices And Should Balloons Be Drug Coated Or Not
	Presenter(s):Marianne Brodmann, MD Location: Grand Ballroom East, 3rd Floor
11:00 AM - 11:05 AM	New Information On The Safety And Effectiveness Of The Cook Zilver PTX DES Based On An Updated Meta-Analysis And Global Data: When Is It The Best DES; When Is It The Best Treatment: Is Distal Microembolization A Concern
	Presenter(s):Peter A. Schneider, MD / William A. Gray, MD / Sahil A. Parikh, MD / Michael D. Dake, MD Location: Grand Ballroom East, 3rd Floor
11:06 AM - 11:11 AM	Updated 4-Year Results Of The IMPERIAL RCT Head To Head Comparison Of The Eluvia DES (Boston Scientific) With The Zilver PTX DES (Cook): Both Are Safe And Effective: Is There A Difference
	Presenter(s):Stefan Mueller-Huelsbeck, MD / William A. Gray, MD / Thomas Zeller, MD Location: Grand Ballroom East, 3rd Floor
11:12 AM - 11:18 AM	Panel Discussion
NEW INFORMATION ON BTK DCBs AND DESs
11:18 AM - 11:23 AM	Advances In BTK Drug Delivery Technology And DCBs: What Have We Learned From The In.Pact Deep BTK DCB Trial And New Challenges With Treating CLTI Patients
	Presenter(s):Thomas Zeller, MD Location: Grand Ballroom East, 3rd Floor
11:24 AM - 11:29 AM	4-Year Results From The AcoArt II BTK DCB RCT Show Safety With No Increased Mortality And Improved Patency Versus POBA To Treat BTK Lesions
	Presenter(s):Wei Guo, MD / Francesco Liistro, MD Location: Grand Ballroom East, 3rd Floor
11:30 AM - 11:35 AM	Orbital Atherectomy Vessel Preparation To Maximize DCB Efficacy In Calcified BTK Lesions: OPTIMIZE BTK RCT 2-Year Results
	Presenter(s):Thomas Zeller, MD Location: Grand Ballroom East, 3rd Floor
11:36 AM - 11:41 AM	The Sirolimus DCB BTK Era Begins: The Selution DCB (From MedAlliance And Cordis): Why The FDA Considered It A Breakthrough Device: Results From Singapore And Europe Are Promising And Justified The Ongoing SELUTION4BTK IDE Trial: Preliminary Results
	Presenter(s):George L. Adams, MD / Patrick J. Geraghty, MD / Michael K.W. Lichtenberg, MD Location: Grand Ballroom East, 3rd Floor
11:42 AM - 11:47 AM	TBD
11:48 AM - 11:53 AM	Panel Discussion
12:00 PM - 1:00 PM	Lunch Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 26

SESSION 27 SCHEDULE
Wednesday SESSION 27: PROGRESS IN EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY DISEASE CAUSING ADVANCED CLTI: OPTIONS TO SAVE THE “NO OPTION FOR TREATMENT” LIMB OR THE “DESERT FOOT” Location: Grand Ballroom East, 3rd Floor Moderators:TBD
x
1:00 PM - 1:05 PM	No Option CLTI: Why Is It A Misnomer: Hybrid And Other Actual Options For Treatment And Limb Salvage
	Presenter(s):Hisham Rashid, FRCS, FRCS(Gen) Location: Grand Ballroom East, 3rd Floor
1:06 PM - 1:11 PM	TBD
VALUE OF PROSTHETIC (PTFE) TIBIAL BYPASSES
1:12 PM - 1:17 PM	What Are The Best Options For Limb Salvage When A Single Autologous Vein Is Inadequate: Does The BEST-CLI RCT Help
	Presenter(s):Joseph L. Mills, MD Location: Grand Ballroom East, 3rd Floor
1:18 PM - 1:23 PM	PTFE Bypasses To Infrapopliteal Target Arteries Can Save Limbs In Patients Facing Imminent Amputation With No Other Therapeutic Option: They Can Have Worthwhile Long-Term Patency And Limb Salvage Rates: A Multicenter Experience
	Presenter(s):Hasan H. Dosluoglu, MD Location: Grand Ballroom East, 3rd Floor
1:24 PM - 1:29 PM	TBD
1:30 PM - 1:35 PM	For Patients Facing Amputation With No Endo Options Or Useable Vein, PTFE Tibial Bypasses Are A Worthwhile Option That Yields Acceptable Mid-Term Patency And Long-Term Limb Salvage Rates
	Presenter(s):R. Clement Darling III, MD Location: Grand Ballroom East, 3rd Floor
1:36 PM - 1:41 PM	Current Outcomes With PTFE Bypasses To Infrapopliteal (Tibial) Targets: Why Is There Variability Between Surgeons And Institutions: How Does The BEST-CLI Trial Help
	Presenter(s):Matthew T. Menard, MD Location: Grand Ballroom East, 3rd Floor
UPDATE ON FOOT VEIN ARTERIALIZATION FOR CLTI
1:42 PM - 1:47 PM	Long-Term View Of The Role And Value Of Vein Arterialization: Best Way To Do It And Late Results: From The First To Make It Work
	Presenter(s):Pramook Mutirangura, FRCS (Edinburgh) Location: Grand Ballroom East, 3rd Floor
1:48 PM - 1:53 PM	Endovascular And Surgical Venous Arterialization For REAL No Option Patients Facing Amputation From CLTI: Does Neo-Angeogenesis Occur
	Presenter(s):Roberto Ferraresi, MD Location: Grand Ballroom East, 3rd Floor
1:54 PM - 1:59 PM	Pivotal US Trial (PROMISE II), US Feasibility Study (PROMISE I) And European 2-Year Registry Results With Deep Vein Arterialization With The LimFlow Device For CLTI With Gangrene Shows Reasonable Limb Salvage And Wound Healing
	Presenter(s):Daniel G. Clair, MD / Andrej Schmidt, MD / Daniela Branzan, MD Location: Grand Ballroom East, 3rd Floor
2:00 PM - 2:05 PM	Hybrid Superficial Venous Arterialization For REAL No Option CLTI; Step-By-Step Technical Tips And Patterns Of Failure Which Is Common
	Presenter(s):Miguel F. Montero, MD / John H. Rundback, MD, FSIR, FAHA, FSVMB Location: Grand Ballroom East, 3rd Floor
2:06 PM - 2:11 PM	Importance Of Open Surgical Procedures In A Limb Preservation Practice: What Are They And When Should They Be Used: It Is No longer About In Situ Vein Bypasses
	Presenter(s):Richard F. Neville, MD Location: Grand Ballroom East, 3rd Floor
2:12 PM - 2:18 PM	Panel Discussion
END OF SESSION 27

SESSION 28 SCHEDULE
Wednesday SESSION 28: NEW DEVELOPMENTS IN STENTS; PROSTHETIC GRAFTS; ENDOVASCULAR BYPASSES; STENT GRAFTS AND TREATMENT OF IN STENT RESTENOSIS (ISR) Location: Grand Ballroom East, 3rd Floor Moderators:TBD
x
2:18 PM - 2:23 PM	The BioMimics Spiral Flow 3D Stent From Veryan Medical: 3-Year Results In CLTI Patients Show Why It Should Be The Preferred Stent For Fempop Lesions: It Is Also The Most Cost Effective
	Presenter(s):Peter Gaines, MD / Michael K.W. Lichtenberg, MD / Timothy M. Sullivan, MD Location: Grand Ballroom East, 3rd Floor
2:24 PM - 2:29 PM	Value Of Heparin Bonded PTFE Grafts For Femoral To Below-The-Knee Bypasses: A Systematic Review And Meta-Analysis: Are There Advantages To Propaten Grafts: Value To Crural targets
	Presenter(s):Yann Gouëffic, MD, PhD Location: Grand Ballroom East, 3rd Floor
2:30 PM - 2:35 PM	TBD
PERCUTANEOUS BYPASSES
2:36 PM - 2:41 PM	Percutaneous (PQ) Transvenous Fempop PTFE Bypasses With The Torus 2 Device (Now From Endologix): How It Works And Updated Status Of The DETOUR And TORUS Trials In The US With 2-Year Results
	Presenter(s):Sean P. Lyden, MD / Daniel G. Clair, MD / Peter A. Schneider, MD Location: Grand Ballroom East, 3rd Floor
2:42 PM - 2:47 PM	Updated Late European Results Of The Detour PQ Fempop Arterial Bypass Routed Through The Femoral Vein From The DETOUR 1 Trial: Which Open Bypasses Will Be Made Obsolete
	Presenter(s):Dainis K. Krievins, MD / Peter A. Schneider, MD Location: Grand Ballroom East, 3rd Floor
2:48 PM - 2:53 PM	A Novel Technique For Percutaneous Extravascular Fempop Bypass - Routing A PTFE Graft Through The Soft Tissue Of The Thigh: It Is A Transcatheter Technique That Is Clampless, Sutureless, And Without External Exposure: How Is It Done; Advantages And Results
	Presenter(s):Pierre G. Sarradon, MD, MDC / Jean Pierre Becquemin, MD, FRCS Location: Grand Ballroom East, 3rd Floor
2:54 PM - 2:58 PM	Panel Discussion
NEW INFORMATION ON STENT-GRAFTS
2:58 PM - 3:03 PM	How Can IVUS Improve Outcomes When Self-Expanding Stent-Grafts (Viabahn) Are Used To Treat SFA Occlusive Lesions: Technical Tips
	Presenter(s):Eric A. Secemsky, MD, MSc Location: Grand Ballroom East, 3rd Floor
3:04 PM - 3:09 PM	Can Viabahn Stent-Grafts Be Used Safely And Effectively In The SFA For CLTI: From Pooled Multicenter Data: What Are The Limitations Of These Devices
	Presenter(s):Michel M.P. Reijnen, MD, PhD Location: Grand Ballroom East, 3rd Floor
3:10 PM - 3:15 PM	Advantages, Limitations And Results Of Gore VBX BE Stent-Graft For Occlusive Disease In Various Vascular Beds And For F/B/EVAR Branches
	Presenter(s):Rocco Giudice, MD / Ciro Ferrer, MD, PhD Location: Grand Ballroom East, 3rd Floor
TREATMENT OF IN STENT RESTENOSIS (ISR)
3:16 PM - 3:21 PM	Update On The Excimer Laser For Treating ISR: It Has A Role In Crossing And Debulking Difficult Lesions: Technical Tips
	Presenter(s):Craig M. Walker, MD Location: Grand Ballroom East, 3rd Floor
3:22 PM - 3:27 PM	How Best To Treat Long Difficult Complex SFA Lesions Including Those From ISR
	Presenter(s):Sonia Ronchey, MD, PhD Location: Grand Ballroom East, 3rd Floor
3:28 PM - 3:34 PM	Panel Discussion And Break (Visit Exhibits And Pavilions – 2nd and 3rd Floors)
END OF SESSION 28

SESSION 29 SCHEDULE
Wednesday SESSION 29: LOWER EXTREMITY TRIALS; GUIDELINES; FOOT PERFUSION EVALUATION METHODS AND VALUE OF ANGIOSOMES Location: Grand Ballroom East, 3rd Floor Moderators:TBD
x
3:40 PM - 3:45 PM	The Japanese SPINACH Registry Confirms That Open Bypasses Are Superior To Endovascular Treatments In CLTI Patients When Ischemia And Infection Are Advanced
	Presenter(s):Nobuyoshi Azuma, MD Location: Grand Ballroom East, 3rd Floor
3:46 PM - 3:51 PM	The Global Vascular Guidelines And WIfI Staging For CLTI Are Better Than Obsolete TASC Guidelines Because Treatment Recommendations, Revascularization Strategies And Needs For The Future Are Not Solely Based On Lesion Anatomy But Are Nuanced By Other Factors: What Are They
	Presenter(s):Michael S. Conte, MD Location: Grand Ballroom East, 3rd Floor
3:52 PM - 3:57 PM	Ancillary Outcomes Of The BEST-CLI RCT Comparing Endovascular And Open Treatment For CLTI When Both Treatments Are Feasible; What Are The Deficiencies IN BEST-CLI And Why Might Interventionalists Claim It Is Misleading
	Presenter(s):Alik Farber, MD, MBA / Matthew T. Menard, MD / Kenneth Rosenfield, MD Location: Grand Ballroom East, 3rd Floor
3:58 PM - 4:03 PM	Why Many Interventionalists Believe The Conclusions Of Best-CLI Are Misleading
	Presenter(s):Sahil A. Parikh, MD Location: Grand Ballroom East, 3rd Floor
4:04 PM - 4:09 PM	Key Results Findings From The Just Completed BASIL 2 RCT Comparing Open And Endovascular Treatments For Severe Leg Ischemia: How Do They Mesh With BEST CLI Results
	Presenter(s):Andrew W. Bradbury, MD, FRCSEd Location: Grand Ballroom East, 3rd Floor
4:10 PM - 4:18 PM	Panel Discussion
METHODS FOR EVALUATING FOOT PERFUSION
4:19 PM - 4:24 PM	How And Why To Measure Foot Perfusion During And After Endo Treatments: Hyperspectral Imaging, O2 Sensors, etc: When Is The Angiosome Concept Helpful; When Not
	Presenter(s):Marianne Brodmann, MD Location: Grand Ballroom East, 3rd Floor
4:25 PM - 4:30 PM	New Methods For Evaluating The Significance Of Lower Extremity Arterial Lesions And Foot Perfusion Using Fractional Flow Reserve (FFR) And MRI; How They Work And Their Value In Assessing Therapeutic Success
	Presenter(s):Bijan Modarai, PhD, FRCS Location: Grand Ballroom East, 3rd Floor
4:31 PM - 4:36 PM	With Endovascular Treatment For CLTI With Tissue Necrosis Pedal Arch Patency Is Key To Predicting Limb Salvage: How Is It Best Evaluated
	Presenter(s):Hasan H. Dosluoglu, MD / Linda M. Harris, MD Location: Grand Ballroom East, 3rd Floor
4:37 PM - 4:42 PM	What Are The Best Methods For Measuring Foot Perfusion: They Are Invaluable In CLTI For Assessing Treatment Success And Predicting Healing
	Presenter(s):Werner Lang, MD Location: Grand Ballroom East, 3rd Floor
4:43 PM - 4:48 PM	Panel Discussion
END OF SESSION 29

SESSION 30 SCHEDULE
Wednesday SESSION 30: NEW DEVELOPMENTS IN THE TREATMENT OF INTERMITTENT CLAUDICATION (IC) AND ACUTE LIMB ISCHEMIA (ALI) Location: Grand Ballroom East, 3rd Floor Moderators:TBD
x
INTERMITTENT CLAUDICATION (IC)
4:48 PM - 4:53 PM	A RCT After 2 Years Showed That Stent Treatment For Intermittent Claudication (IC) Improves Quality Of Life More Than Medical Treatment And Exercise: Do The Long-Term Results Refute Or Negate The 2-Year Results
	Presenter(s):Hans Lindgren, MD, PhD Location: Grand Ballroom East, 3rd Floor
4:54 PM - 5:00 PM	At 2 Years After Endovascular Interventions For IC, Only 32% Of Patients Were Free From Recurrent IC: From A VQI Multicenter Study: What Are The Implications
	Presenter(s):Karen Woo, MD, PhD Location: Grand Ballroom East, 3rd Floor
5:00 PM - 5:05 PM	When Are Invasive Vascular Treatments Justified For IC And When Are They Not: What Is The Evidence
	Presenter(s):Caitlin W. Hicks, MD, MS / James H. Black, III, MD Location: Grand Ballroom East, 3rd Floor
5:06 PM - 5:11 PM	TBD
5:12 PM - 5:16 PM	Panel Discussion
ACUTE LIMB ISCHEMIA (ALI) (See Also Session 63)
5:16 PM - 5:21 PM	Key Points In The Diagnosis And Treatment Of ALI In The Lower Limbs: When To Use Endovascular Treatments And When To Use Open Treatments With Thrombectomy Or A Bypass Because Such ALI Is Always Associated With Chronic Occlusive Disease
	Presenter(s):Martin Bjorck, MD, PhD Location: Grand Ballroom East, 3rd Floor
5:22 PM - 5:27 PM	Different Options For Thrombosuction Devices For Thrombo-Embolectomy For Treating ALI: Which Device In Which Circumstance: When Is Their Use Limited Or Ineffective
	Presenter(s):Athanasios Katsargyris, MD / Eric L.G. Verhoeven, MD, PhD Location: Grand Ballroom East, 3rd Floor
5:28 PM - 5:33 PM	Endovascular Mechanical Thrombectomy Is Obviating The Need For Thrombolytics In ALI: Which Device Is Best – When And Why
	Presenter(s):Patrick E. Muck, MD, FACS Location: Grand Ballroom East, 3rd Floor
5:34 PM - 5:39 PM	Percutaneous Vacuum Thrombectomy For ALI: Devices And Techniques: In 2023 When Is There A Role For Thrombolytics, Angioplasty, Open Balloon Catheter Thrombectomy Or A Bypass
	Presenter(s):Scott L. Stevens, MD Location: Grand Ballroom East, 3rd Floor
5:40 PM - 5:45 PM	What Is New With Penumbra Indigo Clot Aspiration Systems: What Makes Them Different: Indications And Contraindications
	Presenter(s):James F. Benenati, MD Location: Grand Ballroom East, 3rd Floor
5:46 PM - 5:51 PM	Update On How To Treat ALI Under Duplex Ultrasound Guidance: Advantages And Limitations
	Presenter(s):Natalie A. Marks, MD, RPVI, RVT, FSVM / Enrico Ascher, MD Location: Grand Ballroom East, 3rd Floor
5:52 PM - 5:57 PM	The STRIDE Multicenter Trial Showed That Mechanical Suction Thrombectomy With The Indigo Aspiration System (Penumbra) For Lower Limb ALI Had A Low Complication Rate And Excellent Limb Salvage: When Was Angioplasty, Stenting Or A Bypass Necessary
	Presenter(s):Thomas S. Maldonado, MD Location: Grand Ballroom East, 3rd Floor
5:58 PM - 6:02 PM	Panel Discussion End of Program D
END OF SESSION 30

SESSION 31 SCHEDULE
Wednesday SESSION 31: ADVANCES IN MEDICAL TREATMENTS, NEW ANTI-ATHEROGENIC DRUGS, VALUE OF RIVAROXABAN AND PREVENTING MIs IN VASCULAR SURGERY PATIENTS Location: Grand Ballroom West, 3rd Floor Moderators:TBD
x
6:40 AM - 6:45 AM	When, Why And How To Lower High Triglyceride Levels: Value Of Vascepa To Decrease Cardiac Risk In Vascular Patients: Based On The REDUCE-IT RCT
	Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC Location: Grand Ballroom West, 3rd Floor
6:46 AM - 6:51 AM	New Strategies On How To Avoid And Treat Periprocedural Myocardial Infarctions (MIs) In Open Endo Vascular Surgery Patients
	Presenter(s):Peter Henke, MD Location: Grand Ballroom West, 3rd Floor
6:52 AM - 6:57 AM	DEBATE: LDL Cholesterol (LDL-C) Lowering And Statins For Prophylaxis Of Vascular Events Are Dangerous And Not Helpful: What Does The Latest Evidence Show
	Presenter(s):Sherif A.H. Sultan, MD, PhD, FRCS, EBQS-VASC, FACS Location: Grand Ballroom West, 3rd Floor
6:58 AM - 7:03 AM	DEBATE: Not So: Update On LDL-C Lowering With Statins And Other Drugs Stabilizes And Shrinks Plaques And Decreases Morbid Vascular Events: Stopping Statins Increases Patients’ Risk Of MI And Death
	Presenter(s):Ron Waksman, MD Location: Grand Ballroom West, 3rd Floor
7:04 AM - 7:09 AM	Update On LDL-C Lowering During A Lifetime: How Low To Strive For With Intensive Drug Therapy: How Young To Start If High; How Old To Continue Statins: Why And How Often Should LDL-C Levels Be Measured
	Presenter(s):J. David Spence, MD Location: Grand Ballroom West, 3rd Floor
7:10 AM - 7:15 AM	LDL-C Lowering Should Be Maximized With High Dose Statins And Ezetimibe (Zetia) To Minimize Risks From Atherosclerotic Lesions: The LDL-C Level Cannot Be Too Low And Side Effects Are Minor: LDL-C Levels Must Be Monitored And Treated To A Target Level
	Presenter(s):Anne L. Abbott, MD, PhD, FRACP Location: Grand Ballroom West, 3rd Floor
7:16 AM - 7:21 AM	New Findings From The VOYAGER PAD And COMPASS Trials With Low Dose Rivaroxaban (Xarelto From Janssen And J&J) And Aspirin: How Do These Drugs Lower Major Adverse Limb And Cardiac Event Rates After Lower Extremity Revascularization (Endo And Open) For PAD
	Presenter(s):Marianne Brodmann, MD / Sebastian E. Debus, MD, PhD Location: Grand Ballroom West, 3rd Floor
7:22 AM - 7:27 AM	How Does The Morbidity And Pathology Of Adverse Events With Arteriosclerosis Depend On Thrombosis: This Explains The Benefits Of Rivaroxaban And Aspirin Seen In The VOYAGER And COMPASS Trials
	Presenter(s):Anthony J. Comerota, MD, FACS, FACC Location: Grand Ballroom West, 3rd Floor
7:28 AM - 7:33 AM	New Adjunctive Drugs (Plus Statins) To Lower LDL-Cholesterol (LDL-C) In Vascular Patients: Inclisiran, Bempedoic Acid And Ezetimibe: How Do They Work And When And How To Use Them: Level Of LDL-C To Strive For: The CLEAR RCT Show That Bempedoic Acid Really Works
	Presenter(s):Richard Bulbulia, MA, MD, FRCS Location: Grand Ballroom West, 3rd Floor
7:34 AM - 7:42 AM	Panel Discussion
END OF SESSION 31

SESSION 32 SCHEDULE
Wednesday SESSION 32: CATHETER BASED TREATMENTS OF RESISTANT HYPERTENSION; MANAGEMENT OF CARDIAC PROBLEMS, SMOKING AND TRANSFUSION IN VASCULAR SURGERY PATIENTS; MORTALITY RISK IN STROKE PATIENTS; PREVENTING VASCULAR AND CARDIAC COMPLICATIONS Location: Grand Ballroom West, 3rd Floor Moderators:TBD
x
UPDATE ON RENAL DENERVATION FOR HYPERTENSION
7:42 AM - 7:47 AM	Update On The Status Of Renal Denervation For Hypertension: It Is Here To Stay: Where Is It Going: Status Of The Radiofrequency Denervation SPYRAL HTN-OFF MED RCT (vs Sham) And Other Catheter Based Ablative And Ultrasound Methods (The RADIANCE II RCT Findings)
	Presenter(s):Eric A. Secemsky, MD, MSc Location: Grand Ballroom West, 3rd Floor
7:48 AM - 7:53 AM	Multiorgan Denervation For Treatment OF Hypertension, Diabetes And Metabolic Syndrome: How To Do It
	Presenter(s):Horst Sievert, MD Location: Grand Ballroom West, 3rd Floor
7:54 AM - 7:59 AM	A Precision Medicine Approach To Managing Pediatric Renovascular Hypertension: How Can Medical And Open Surgical Treatment Control It
	Presenter(s):Dawn M. Coleman, MD Location: Grand Ballroom West, 3rd Floor
OTHER TOPICS RELATED TO VASCULAR DISEASE AND ITS TREATMENT
8:00 AM - 8:05 AM	How Does The Female Sex Impact The Occurrence Of Lower Extremity Atherosclerosis, Its Treatment And Results Of Treatment
	Presenter(s):Katherine A. Gallagher, MD Location: Grand Ballroom West, 3rd Floor
8:06 AM - 8:11 AM	How And Why Do Thoracic Endografts For TEVAR Negatively Affect The Blood Pressure And The Heart: Can A Compliant Endograft Prevent The Problem
	Presenter(s):Juan C. Parodi, MD Location: Grand Ballroom West, 3rd Floor
8:12 AM - 8:17 AM	When Should Smoking Be Stopped Before AAA Repair; Before Lower Extremity Bypass: At Least 4 Weeks: Why Does The Duration Of Cessation Matters
	Presenter(s):Jeffrey J. Siracuse, MD, MBA, FACS Location: Grand Ballroom West, 3rd Floor
8:18 AM - 8:23 AM	Update On Limiting Transfusion And Permitting Anemia After Major Vascular Operations Increases Mortality And Serious Adverse Events Especially In Patients With Cardiac Co-Morbidities
	Presenter(s):Panos Kougias, MD, MSc Location: Grand Ballroom West, 3rd Floor
8:25 AM - 8:29 AM	How To Quantitate Late Mortality Risk In Asymptomatic Carotid Stenosis (ACS) Patients: Why It’s Important In Deciding To Treat ACS Patients Non-Invasively
	Presenter(s):Stavros K. Kakkos, MD, PhD / Andrew N. Nicolaides, MS, FRCS Location: Grand Ballroom West, 3rd Floor
8:30 AM - 8:35 AM	Secondary Prevention Of Vascular Disease And Its Complication With PCSK9 Inhibitors; When They Should Be Used And When Not: How Well Does The New Oral PCSK9 (Inhibitor MK-01616 Work)
	Presenter(s):Roxana Mehran, MD Location: Grand Ballroom West, 3rd Floor
8:36 AM - 8:41 AM	How Important Is Inflammation As Determined By C-Reactive Protein (CRP) Levels In Predicting Adverse Cardiac Events: What Drugs Can Lower This Risk
	Presenter(s):Ron Waksman, MD Location: Grand Ballroom West, 3rd Floor
8:42 AM - 8:50 AM	Panel Discussion
8:50 AM - 9:06 AM	Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 32

SESSION 33 SCHEDULE
Wednesday SESSION 33: PROGRESS IN MANAGING ENDOLEAKS: UNDERSTANDING THEIR CONSEQUENCES AND PREDICTING, PREVENTING AND TREATING THEM Location: Grand Ballroom West, 3rd Floor Moderators:TBD
x
TO TREAT OR NOT TO TREAT TYPE 2 ENDOLEAKS
9:06 AM - 9:11 AM	Active AAA Sac Management With Polymers: This Is The Missing Link To Improve Outcomes After EVAR: Technique And Results From The SHAPE AAA Trial (From Shape Memory)
	Presenter(s):Michel M.P. Reijnen, MD, PhD / Andrew Holden, MBChB Location: Grand Ballroom West, 3rd Floor
9:12 AM - 9:17 AM	Fibrin Glue Sac Filling Technique During EVAR To Prevent All Endoleaks: It Should Be Routine And Is A Game Changer Based On A Multicenter Trial: How To Do It
	Presenter(s):Qingsheng Lu, MD Location: Grand Ballroom West, 3rd Floor
TREATING TYPE 1 ENDOLEAKS
9:18 AM - 9:23 AM	Post EVAR Type 1A Endoleaks Are Predictable And Preventable: Strategies To Prevent Them Or Treat Them
	Presenter(s):Michael J. Singh, MD Location: Grand Ballroom West, 3rd Floor
9:24 AM - 9:29 AM	Can Gluing Be Effective Treatment For Small Type 1A Endoleaks: Under What Circumstances And Technique
	Presenter(s):Thomas S. Maldonado, MD / Neal S. Cayne, MD Location: Grand Ballroom West, 3rd Floor
9:30 AM - 9:35 AM	When And How To Use Embolization Coils To Treat Type 1A Endoleaks Successfully: When Won’t Coils Work: How To Diagnose Type 1A Endoleaks Accurately
	Presenter(s):Sigrid Nikol, MD Location: Grand Ballroom West, 3rd Floor
9:36 AM - 9:41 AM	How To Minimize Gutter Type 1A Endoleaks With Chimney EVAR (Ch/EVAR): How Does A Standard Protocol Help; How To Treat Them When They Occur
	Presenter(s):David J. Minion, MD Location: Grand Ballroom West, 3rd Floor
9:42 AM - 9:48 AM	Panel Discussion
9:49 AM - 9:54 AM	A RCT Shows The Advantages Of Inferior Mesenteric Artery (IMA) And Lumbar Embolization: The Next Generation Of EVAR Endografts Must Prevent Endoleaks: How Can It Be Done
	Presenter(s):Dominique Fabre, MD, PhD / Stephan Haulon, MD Location: Grand Ballroom West, 3rd Floor
9:55 AM - 10:00 AM	Preventing Threatening Type 2 Endoleaks By IMA Embolization When AAA Sac And IMA Are Large: Indications And Technical Tips And Evidence
	Presenter(s):Toru Kuratani, MD, PhD Location: Grand Ballroom West, 3rd Floor
10:01 AM - 10:06 AM	With A Large IMA (> 3mm), When Should It Be Embolized; Or When Should It Be Revascularized: How And Why
	Presenter(s):Piotr M. Kasprzak, MD Location: Grand Ballroom West, 3rd Floor
10:07 AM - 10:12 AM	Reduction Of Type 2 Endoleaks By Pre-Emptive Coiling Of Aortic Side Branches >3 mm: How Do We Know Based On A Mid-Term Analysis
	Presenter(s):Götz M. Richter, MD, PhD Location: Grand Ballroom West, 3rd Floor
10:13 AM - 10:19 AM	Panel Discussion
TREATMENT OF TYPE 2 ENDOLEAKS AND ENDOTENSION AFTER EVAR
10:20 AM - 10:25 AM	Transcaval Approach To Treat Type 2 Endoleaks After EVAR: Indications: Technique; Precautions And Results
	Presenter(s):Ross Milner, MD Location: Grand Ballroom West, 3rd Floor
10:26 AM - 10:31 AM	Glue Embolization Is Effective Treatment For Most Threatening Type 2 Endoleaks: When And How Best To Do It: Limitations
	Presenter(s):Neal S. Cayne, MD Location: Grand Ballroom West, 3rd Floor
10:32 AM - 10:37 AM	TBD
10:38 AM - 10:43 AM	How To Use 3D Fusion Software (GE) To Get Into The Nidus And Treat Type 2 Endoleaks: Best Embolic Agent And Alternate Approaches (Transgraft Or Transcaval) For Access: How To Seal The Graft Puncture Site
	Presenter(s):Mark W. Mewissen, MD, RVT Location: Grand Ballroom West, 3rd Floor
10:44 AM - 10:49 AM	Laser Assisted Transgraft Onyx Embolization Of Type 2 Endoleaks: Indications, Equipment And Technique
	Presenter(s):Zvonimir Krajcer, MD, FACC Location: Grand Ballroom West, 3rd Floor
10:50 AM - 10:55 AM	Most Type 2 Endoleaks After EVAR Should Be Left Alone Because Treatments Have Poor Results, Have Complications And Do Not Improve Outcomes: Are There Exceptions
	Presenter(s):Hence J.M. Verhagen, MD, PhD Location: Grand Ballroom West, 3rd Floor
10:56 AM - 11:01 AM	With Type 2 Endoleaks And Sac Expansion, Open Sacotomy And Branch Ligation Is Often The Best Treatment: What Precautions Are Needed In Case There Is An Occult Type 1 Leak
	Presenter(s):Zachary M. Arthurs, MD Location: Grand Ballroom West, 3rd Floor
11:02 AM - 11:11 AM	Panel Discussion
END OF SESSION 33

SESSION 34 SCHEDULE
Wednesday SESSION 34: TCT AND PLINIO ROSSI RECORDED LIVE COMPLEX AND CHALLENGING ENDOVASCULAR CASES Location: Grand Ballroom West, 3rd Floor Moderators:TBD
x
TCT RECORDED LIVE CHALLENGING ENDOVASCULAR CASES
Moderator(s): Juan F. Granada, MD / Sahil A. Parikh, MD
11:12 AM - 11:36 AM	PROGRAM TO BE DETERMINED
PLINIO ROSSI’S RECORDED LIVE COMPLEX AND CHALLENGING ENDO CASES
Moderator(s): Fabrizio Fanelli, MD, EBIR / Andrew Holden, MBChB / Carlo Setacci, MD
11:36 AM - 12:00 PM	PROGRAM TO BE DETERMINED
12:00 PM - 1:00 PM	Lunch Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 34

SESSION 35 SCHEDULE
Wednesday SESSION 35: RECORDED LIVE CHALLENGING CASES AND INNOVATIVE TECHNIQUES FROM THE LINC GROUP Location: Grand Ballroom West, 3rd Floor Moderators:TBD
x
1:00 PM - 1:32 PM	PROGRAM TO BE DETERMINED
END OF SESSION 35

SESSION 36 SCHEDULE
Wednesday SESSION 36: ISSUES IMPORTANT IN VASCULAR SURGERY: PRACTICE PATTERNS, HISTORY, EFFICIENCY, MALPRACTICE, SCIENCE, TRAINING AND HUMAN BEHAVIOR Location: Grand Ballroom West, 3rd Floor Moderators:TBD
x
1:33 PM - 1:38 PM	Care Fragmentation In Vascular Treatment: What Is It; What Are Its Causes And What Is Its Impact On Outcomes After Vascular Procedures
	Presenter(s):Olamide Alabi, MD / William D. Jordan Jr., MD Location: Grand Ballroom West, 3rd Floor
1:39 PM - 1:44 PM	History Of Women In Surgery And Vascular Surgery: What Does The Future Hold Within The Next 10 Years
	Presenter(s):Cynthia K. Shortell, MD Location: Grand Ballroom West, 3rd Floor
1:45 PM - 1:50 PM	How To Improve Operating Room Efficiency For Vascular Surgical Operations: Why Is Inefficiency In This Setting So Widespread And Hard To Fix
	Presenter(s):Panos Kougias, MD, MSc Location: Grand Ballroom West, 3rd Floor
1:51 PM - 1:56 PM	Patient Reported Outcomes (PROs): What Are They: Importance And Pitfalls: How Do They Differ From Patient Satisfaction
	Presenter(s):Christopher J. Smolock, MD Location: Grand Ballroom West, 3rd Floor
1:57 PM - 2:02 PM	Why Non-Compete Clauses In Contracts Should be Eliminated By Law: The SVS Position In Favor Of Such Law Contrasts With The AHA Position Against
	Presenter(s):Margaret C. Tracci, MD, JD Location: Grand Ballroom West, 3rd Floor
2:03 PM - 2:08 PM	Why Systematic Reviews, Meta-Analyses And RCTs Can Be Misleading: What To Do About It: Does Current Wisdom Help
	Presenter(s):Janet T. Powell, MD, PhD Location: Grand Ballroom West, 3rd Floor
ISSUES IN VASCULAR TRAINING
2:09 PM - 2:14 PM	Optimal New Training Paradigm For Vascular Surgeons: 0+5 Vascular Surgery Residency Followed By 2 Years Of Cardiac Surgery Residency Training: Why Is It Better Than 2 Extra Years Of Laboratory Research
	Presenter(s):Alan B. Lumsden, MD, FACS Location: Grand Ballroom West, 3rd Floor
2:15 PM - 2:20 PM	Integrated (0+5) Vascular Residency Plus CT Surgery Fellowship – How Many Are There; Are They Over Trained And Underutilized: How Has It Helped Me
	Presenter(s):Jennifer L. Perri, MD, MBA Location: Grand Ballroom West, 3rd Floor
2:21 PM - 2:26 PM	Is Vascular Surgery Facing A Looming Decline Because Of Inadequate Numbers Of Both 5+2 And 0+5 Training Programs: What Should And Can Be Done About It: What Are The Impediments
	Presenter(s):Michael B. Silva, Jr., MD Location: Grand Ballroom West, 3rd Floor
2:27 PM - 2:32 PM	How To Remedy The Deficiency Vascular Fellows And Residents Have In Their Numbers Of Open Vascular Surgical Operations: When Should They Get Additional Subspecialty Training In Another Institution
	Presenter(s):Malachi Sheahan, MD Location: Grand Ballroom West, 3rd Floor
2:33 PM - 2:38 PM	TBD
2:39 PM - 2:44 PM	How Human Behavior – Even With Vascular Specialists – Is Controlled By Biases And Rationalizations: How To Overcome These And Perform Better
	Presenter(s):Scott L. Stevens, MD Location: Grand Ballroom West, 3rd Floor
2:45 PM - 2:58 PM	Panel Discussion And Break (Visit Exhibits And Pavilions – 2nd and 3rd Floors)
END OF SESSION 36

SESSION 37 SCHEDULE
Wednesday SESSION 37: MORE ISSUE-RELATED TOPICS IMPORTANT TO VASCULAR SURGEONS AND VASCULAR SPECIALISTS; ISSUES RELATED TO OUTPATIENT CENTERS OR OFFICE BASED LABS (OBLs) Location: Grand Ballroom West, 3rd Floor Moderators:TBD
x
2:58 PM - 3:03 PM	How COVID And Changes In The Economy Have Caused Hospitals To Run Out Of Money; What Is The Resulting Impact On Vascular Care And Vascular Doctors; What Can Be Done About It
	Presenter(s):Samuel R. Money, MD, MBA Location: Grand Ballroom West, 3rd Floor
3:04 PM - 3:09 PM	DEBATE: How Heart And Vascular Centers Are Attracting Private Equity Investment Leading To Benefits For All Concerned Including Vascular Surgeons And Their Patients
	Presenter(s):Jean Bismuth, MD Location: Grand Ballroom West, 3rd Floor
3:10 PM - 3:15 PM	DEBATE: Heart And Vascular Centers Are Artificial Entities That Disadvantage Vascular Surgeons And Don’t Improve Patient Care
	Presenter(s):Malachi Sheahan, MD Location: Grand Ballroom West, 3rd Floor
3:16 PM - 3:21 PM	Vascular Spinoff Revenue In Tertiary Healthcare Systems: Substantially More Downstream Benefits FROM Vascular Surgeons: How To Make Hospital Administrators Appreciate The Value Of Vascular Surgeons And Reward Them Appropriately
	Presenter(s):Joseph V. Lombardi, MD, MBA Location: Grand Ballroom West, 3rd Floor
ISSUES RELATED TO OUTPATIENT CENTERS AND OBLs
3:22 PM - 3:27 PM	The Ever Changing Reimbursement For Lower Extremity Endovascular Therapies In Hospitals And OBLs: Why It’s Happening And Where Is It Going
	Presenter(s):Sean P. Roddy, MD / Robert M. Zwolak, MD, PhD Location: Grand Ballroom West, 3rd Floor
3:28 PM - 3:33 PM	Strategies To Succeed In An OBL Despite Continuing Cuts In CMS Reimbursement
	Presenter(s):Clifford M. Sales, MD, MBA, FACS Location: Grand Ballroom West, 3rd Floor
3:33 PM - 3:39 PM	Panel Discussion
MORE ISSUES RELATED TO OUTPATIENT CENTERS AND OBLs
3:40 PM - 3:45 PM	DEBATE: OBLs Are Bad: Why I Choose Not To Work In An OBL
	Presenter(s):Dipankar Mukherjee, MD Location: Grand Ballroom West, 3rd Floor
3:46 PM - 3:51 PM	DEBATE: Not True! How Can OBLs Provide Good Vascular Care With Excellent Results, Be Profitable And Still Allow Vascular Surgeons To Only Work From 8 AM To 5 PM
	Presenter(s):Mark A. Mattos, MD Location: Grand Ballroom West, 3rd Floor
3:52 PM - 3:57 PM	How To Make Out-Patient Vascular Treatment Facilities (OBLs, ASCs) Safe, Effective And Profitable Without Doing Unjustified Procedures
	Presenter(s):Christopher J. Kwolek, MD, MBA Location: Grand Ballroom West, 3rd Floor
3:58 PM - 4:03 PM	Comparison of Arterial Closure Devices In An OBL Setting: Which Is Best Based On An Experience With 19000 Cases
	Presenter(s):Sam S. Ahn, MD, FACS, MBA Location: Grand Ballroom West, 3rd Floor
4:04 PM - 4:09 PM	Tips For Performing High-Risk Lower Extremity Endovascular Procedures Including Redos Safely And Effectively In An OBL
	Presenter(s):Anil P. Hingorani, MD / Enrico Ascher, MD Location: Grand Ballroom West, 3rd Floor
4:10 PM - 4:15 PM	OBL Audits: What Are They Looking For And How To Avoid Civil And Criminal Penalties: Do Practice Guidelines Help Or Harm
	Presenter(s):O. William Brown, MD, JD Location: Grand Ballroom West, 3rd Floor
4:16 PM - 4:21 PM	Panel Discussion
END OF SESSION 37

SESSION 38 SCHEDULE
Wednesday SESSION 38: UPDATES AND ISSUES IMPORTANT TO ALL VASCULAR SURGEONS AND SPECIALISTS: FUTURE REIMBURSEMENT; VASCULAR REGISTRIES AND THE VQI, VALUE OF GUIDELINES AND RCTs: THE FDA: STAISTICS; EVIDENCE BASED MEDICINE; MISCELLANEOUS Location: Grand Ballroom West, 3rd Floor Moderators:TBD
x
4:22 PM - 4:27 PM	What Obstacles And Blows Are Vascular Surgeons And Other Vascular Specialists Facing In 2023: Will Planned Increased Reimbursement For Office And Hospital Visits Cause More Decreases In Procedural Reimbursements
	Presenter(s):Sean P. Roddy, MD Location: Grand Ballroom West, 3rd Floor
4:28 PM - 4:33 PM	VQI Collaboration With The International Consortium of Vascular Registries (ICVR): How Can It Better Evaluate Aortic Endograft Performance In Ruptured Aneurysms
	Presenter(s):Adam Beck, MD Location: Grand Ballroom West, 3rd Floor
4:34 PM - 4:39 PM	The Role And Value Of Guidelines And RCTs In Vascular Practice; Why Guidelines And RCTs Can Be Misleading: What To Do About The Problem
	Presenter(s):Anders Wanhainen, MD, PhD Location: Grand Ballroom West, 3rd Floor
REGULATORY AND FDA ISSUES
4:40 PM - 4:45 PM	How Can A Device Qualify With The FDA For BREAKTHROUGH Status And How Does It Differ From SAFER Status
	Presenter(s):Valerie M. Merkle, PhD Location: Grand Ballroom West, 3rd Floor
4:46 PM - 4:51 PM	Past, Present And Future Collaboration Between Industry, Clinicians And The FDA To Address Unmet Clinical Needs: We Should Not Be Adversaries
	Presenter(s):Dorothy B. Abel, BSBME Location: Grand Ballroom West, 3rd Floor
EVIDENCE BASED MEDICINE ISSUES
4:52 PM - 4:57 PM	Improved And Simplified Clinical Trial Statistics For Dummies: Why p Values Are Decreasing In Importance And Bayesian Statistics Are Increasing In Importance: What Is The Latter
	Presenter(s):Charles C. Miller, PhD Location: Grand Ballroom West, 3rd Floor
4:58 PM - 5:03 PM	Registry Based RCTs: What Are They And Why Are They Better Than Other Evidence Based Techniques
	Presenter(s):Jens Eldrup-Jorgensen, MD / Jack L. Cronenwett, MD Location: Grand Ballroom West, 3rd Floor
5:04 PM - 5:09 PM	Panel Discussion
MISCELLANEOUS
5:10 PM - 5:15 PM	Managing Various Specialties And Generations Of Specialists In A Multi-Specialty Vascular Institute Or Center: How To Satisfy Everyone And Optimize Patient Outcomes
	Presenter(s):Gary M. Ansel, MD Location: Grand Ballroom West, 3rd Floor
5:16 PM - 5:21 PM	Despite What The New York Times And Others Say, Close Relationships Of Vascular Surgeons With Industry Are Mostly Ethical And Beneficial To Patients And Society: Pitfalls To Avoid
	Presenter(s):Bruce A. Perler, MD, MBA Location: Grand Ballroom West, 3rd Floor
5:22 PM - 5:27 PM	Innovation In Vascular Surgery: Ideas, Funding, Partners And Intellectual Property: How To Turn Fantasy Into Reality
	Presenter(s):Jeffrey H. Lawson, MD, PhD Location: Grand Ballroom West, 3rd Floor
5:28 PM - 5:33 PM	Current Quality Analysis For Vascular Surgeons And Vascular Specialists Does Not Reflect Quality Of Care: Why And What Can Be Done About It
	Presenter(s):Richard F. Neville, MD Location: Grand Ballroom West, 3rd Floor
5:34 PM - 5:39 PM	Editorial Update On The JVS And All Its Progeny: Its Status And How It Will Be Improved
	Presenter(s):Ronald L. Dalman, MD / Thomas L. Forbes, MD Location: Grand Ballroom West, 3rd Floor
5:40 PM - 5:45 PM	Effects Of The Affordable Care Act (ACA) On Vascular Surgical Outcomes: Does The Medicaid Expansion Of The ACA Improve Outcomes Or Not
	Presenter(s):Mohammad H. Eslami, MD, MPH Location: Grand Ballroom West, 3rd Floor
5:46 PM - 5:52 PM	Panel Discussion End of Program E
END OF SESSION 38

SESSION 39 SCHEDULE
Wednesday SESSION 39: MORE TOPICS RELATED TO THE THORACIC AORTA, AORTIC DISSECTIONS, INTRAMURAL HEMATOMAS (IMHs), INFLAMMATORY ANEURYSMS AND THEIR TREATMENT Location: Trianon Ballroom, 3rd Floor Moderators:TBD
x
6:50 AM - 6:55 AM	What Is Best Medical Treatment For TBAD Patients: How Best To Control Blood Pressure And To Get Patients To Comply: They Don’t
	Presenter(s):Colin D. Bicknell, MD, FRCS Location: Trianon Ballroom, 3rd Floor
6:56 AM - 7:01 AM	Requirement For Adjunctive Branch Stents After TEVAR For Complicated TBADs Is An Indicator Of Poor Prognosis: What Can Be Done To Offset It
	Presenter(s):Mark K. Eskandari, MD Location: Trianon Ballroom, 3rd Floor
7:02 AM - 7:07 AM	Current Optimal Management Of Intramural Hematomas (IMH): Which Ones Should Be Treated With TEVAR And What Is The Best Extent Of Aortic Coverage
	Presenter(s):Frank J. Criado, MD Location: Trianon Ballroom, 3rd Floor
7:08 AM - 7:13 AM	Outer/ Inner/Upward Branches Or Fenestrations: Strategies For Complex Aortic Repair For Patients With Chronic TBADs: What Are The Unmet Needs
	Presenter(s):Bijan Modarai, PhD, FRCS Location: Trianon Ballroom, 3rd Floor
7:14 AM - 7:19 AM	Current Advances In The Treatment For Inflammatory Aneurysms: How Effective Are EVAR And TEVAR
	Presenter(s):Furuzan Numan, MD Location: Trianon Ballroom, 3rd Floor
7:20 AM - 7:25 AM	Panel Discussion
7:25 AM - 7:30 AM	DEBATE: The Stabilize Technique Will Lead To Paradigm Shift In The Treatment Of TBADs And Will Replace Most False Lumen Occlusion Devices And F/B/EVAR Treatments: It Relaminates The Aorta And Eliminates The False Lumen: How To Do It And Precautions
	Presenter(s):Igor A. Laskowski, MD, PhD / Josh B. Goldberg, MD / Heepeel Chang, MD Location: Trianon Ballroom, 3rd Floor
7:31 AM - 7:36 AM	DEBATE: Not So Fast! A Multimodular Approach To Treating Chronic TBADs With TAAAs: Who Needs A F/B/EVAR; Who Needs A Candy-Plug Or Other Occlusion Technique
	Presenter(s):Tilo Koelbel, MD, PhD / Fiona Rohlffs, MD Location: Trianon Ballroom, 3rd Floor
7:37 AM - 7:42 AM	When Are Thoracic Endografts Valuable Treatments For Genetic Aortopathies
	Presenter(s):Cherrie Z. Abraham, MD Location: Trianon Ballroom, 3rd Floor
7:43 AM - 7:48 AM	What Are The Knowledge Gaps In The Treatment Of TBADs: How Can And Will They Be Resolved
	Presenter(s):Colin D. Bicknell, MD, FRCS Location: Trianon Ballroom, 3rd Floor
7:49 AM - 7:54 AM	A Recently Funded Multicenter NIH Grant (IMPROVE-AD) To Evaluate Unknowns In The Treatment Of Acute And Subacute TBADs: What Will It Tell Us And When And Why Was It So Hard To Get It Approved: Are There Other Similar RCTs OUS
	Presenter(s):Firas F. Mussa, MD / Gustavo S. Oderich, MD FACS Location: Trianon Ballroom, 3rd Floor
7:55 AM - 8:00 AM	Panel Discussion
END OF SESSION 39

SESSION 41 SCHEDULE
Wednesday SESSION 41: OPEN AND ENDO TREATMENT OF COMPLEX AAAs (JUXTA, PARA- AND SUPRA-RENAL) AND TAAAs; NEW DEVICES FOR THEIR TREATMENT Location: Trianon Ballroom, 3rd Floor Moderators:TBD
x
COMPLEX AAAs AND TAAAs
9:24 AM - 9:29 AM	Aortic Neck Dilatation And AAA Sac Shrinkage After F/EVAR Is Better Than After Standard EVAR
	Presenter(s):Thomas S. Maldonado, MD Location: Trianon Ballroom, 3rd Floor
9:30 AM - 9:35 AM	Recent Progress In Prevention Of Spinal Cord Ischemia (SCI) Especially Paraplegia After Complex AAA And TAAA Endovascular Repairs
	Presenter(s):Matthew J. Eagleton, MD Location: Trianon Ballroom, 3rd Floor
9:36 AM - 9:41 AM	Complete Aortic Endovascular Repairs (Zones 0-10) Using Parallel Endografts With A Docking Station: How And Why To Make Them Work Effectively Despite Doubts About Parallel Grafts
	Presenter(s):Manish Mehta, MD, MPH Location: Trianon Ballroom, 3rd Floor
9:42 AM - 9:47 AM	Value Of Ch/EVAR For Juxtarenal AAAs: They Are As Safe And Effective As Any Other Procedure And Simpler: Based On A Meta-Analysis Of Mid-Term Outcomes
	Presenter(s):Joost van Herwaarden, MD, PhD Location: Trianon Ballroom, 3rd Floor
9:48 AM - 9:53 AM	Key Findings From The UK-Complex Aneurysm Study (UK-COMPASS) Comparing Outcomes Of Off-Label EVAR, Open Repair And F/EVAR For Short Necked AAAs
	Presenter(s):S. Rao Vallabhaneni, MD, FRCS Location: Trianon Ballroom, 3rd Floor
9:54 AM - 9:59 AM	Comparison Of Endo And Open Repair Of Post Dissection TAAAs: Which Procedure Is Best And When
	Presenter(s):Fabio Verzini, MD, PhD, FEBVS Location: Trianon Ballroom, 3rd Floor
10:00 AM - 10:05 AM	What Is A Hybrid Repair Of A TAAA (Proximal Endograft + Distal Open Repair - The Upchurch Procedure): When Is It Indicated; What Are the Advantages And Results
	Presenter(s):Gilbert R. Upchurch, MD / Sal Scali, MD / Dean Arnaoutakis, MD Location: Trianon Ballroom, 3rd Floor
10:06 AM - 10:12 AM	Panel Discussion
TOPICS RELATED TO INTERESTING NEW DEVICES
10:12 AM - 10:17 AM	Update Of A New Hybrid Device (Thoracoflo From Terumo Aortic) For TAAA Repair: How It Works, Clinical Experience And Advantages
	Presenter(s):Sebastian E. Debus, MD, PhD Location: Trianon Ballroom, 3rd Floor
10:18 AM - 10:23 AM	How To Prevent Patch Aneurysms After Open TAAA Repair With Long Antegrade Grafts: How To Treat Them When They Occur
	Presenter(s):Manju Kalra, MBBS Location: Trianon Ballroom, 3rd Floor
10:24 AM - 10:29 AM	Can EVAR And F/EVAR Be Done Under Local Anesthesia: Can They Become Outpatient Procedures Or Office Based Lab Procedures: What Are The Contraindications
	Presenter(s):Michael C. Stoner, MD Location: Trianon Ballroom, 3rd Floor
10:30 AM - 10:35 AM	WeFlow Device For Juxtarenal AAA, TAAA And Arch Repairs: A New Inner Branch And Outer Branch Approach: How Does It Work And Promising Results
	Presenter(s):Wei Guo, MD Location: Trianon Ballroom, 3rd Floor
10:36 AM - 10:40 AM	Panel Discussion
END OF SESSION 41

SESSION 42 SCHEDULE
Wednesday SESSION 42: PROGRESS IN TREATING ILIAC ANEURYSMS; ILIAC BRANCHED DEVICES (IBDs); UPDATE ON MULTILAYER FLOW MODULATING (MLFM) AND OTHER BARE STENTS FOR TREATING ANEURYSMS AND DISSECTIONS Location: Trianon Ballroom, 3rd Floor Moderators:TBD
x
TREATMENT OF ILIAC ANEURYSMS AND IBDs
10:40 AM - 10:45 AM	Surprisingly Occlusion Of 1 Or Both Hypogastric Arteries During EVAR Does NOT Result In Serious Adverse Events: From A Large VQI Study
	Presenter(s):Heepeel Chang, MD Location: Trianon Ballroom, 3rd Floor
10:46 AM - 10:51 AM	Update On The Gore IBE Excluder For Treating Iliac Aneurysms And Preserving Hypogastric Artery Flow: Why It Should Be Preserved Whenever Possible: When Can It Not Be
	Presenter(s):Michel M.P. Reijnen, MD, PhD Location: Trianon Ballroom, 3rd Floor
10:52 AM - 10:57 AM	Updated Experience Including The US-ARC Data With Cook IBD For The Treatment Of Common Iliac Aneurysms: Including After Previous EVAR
	Presenter(s):Giovanni B. Torsello, MD / Carlos H. Timaran, MD / Andres Schanzer, MD Location: Trianon Ballroom, 3rd Floor
10:58 AM - 11:03 AM	Long-Term Comparison Of The Cook Zenith And Gore Excluder IBDs: Advantages And Limitations Of Both: What Is Currently The Best Bridging Stent
	Presenter(s):Giovanni Pratesi, MD Location: Trianon Ballroom, 3rd Floor
11:04 AM - 11:09 AM	An Iliac Customized Fenestrated Device (From Terumo Aortic): When And How Can It Work In Anatomies Unsuitable For Branched Endografts: Advantages And Limitations
	Presenter(s):Afshin Assadian, MD / Fadi Taher, MD Location: Trianon Ballroom, 3rd Floor
11:10 AM - 11:15 AM	Update On The Advantages Of The Artivion (Formerly CryoLife/Jotec) IBD Device Now From Artivion For Treating Common And Internal Iliac Artery Aneurysms: When Bell Bottom Technique; When IBD: From The PLIANT II Study
	Presenter(s):Lee Bouwman, MD, PhD, MSc Location: Trianon Ballroom, 3rd Floor
11:16 AM - 11:22 AM	Panel Discussion
UPDATE ON MULTILAYER FLOW MODULATING (MLFM) AND OTHER BARE STENTS
11:22 AM - 11:27 AM	Why MLFM Bare Stents Should Be The Treatment Of Choice For Visceral, Peripheral And Iliac Aneurysms: Advantages And Has Rupture Been Universally Prevented: What About For TAAAs
	Presenter(s):Michel C. Henry, MD Location: Trianon Ballroom, 3rd Floor
11:28 AM - 11:33 AM	Is There A Role For Bare Stents (Allay From Intressa, Formerly Cardiatis) In The Treatment Of Type A Aortic Dissections (TAADs)
	Presenter(s):Rodney A. White, MD Location: Trianon Ballroom, 3rd Floor
11:34 AM - 11:39 AM	8-Year Clinical Experience With Bare Stent Treatment Of TAADs
	Presenter(s):Ivo Petrov, MD, PhD / Victor S. Costache, MD, PhD Location: Trianon Ballroom, 3rd Floor
11:40 AM - 11:45 AM	3-Year Experience With Bare Stents (Allay From Intressa, Formerly Cardiatis) For The Treatment Of TAADs
	Presenter(s):Claude D. Vaislic, MD Location: Trianon Ballroom, 3rd Floor
11:46 AM - 11:51 AM	Role Of Bare Metal AMDS Stents From Artivion (Formerly CryoLife/Jotec) For Repair Of Acute Type A Dissections: Indications And Results
	Presenter(s):Wilson Y. Szeto, MD / Grayson H. Wheatley, MD Location: Trianon Ballroom, 3rd Floor
11:52 AM - 12:00 PM	Panel Discussion
12:00 PM - 1:00 PM	Lunch Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 42

SESSION 43 SCHEDULE
Wednesday SESSION 43: MORE NEW DEVELOPMENTS IN AAA TREATMENT AND STANDARD EVAR: A NEW DEVICE TO SLOW AAA GROWTH; AAA NECK DILATATION AFTER EVAR; VALUE OF LOW PROFILE AAA ENDOGRAFTS; LINK TO CANCER; IMPROVED ULTRASOUND SURVEILLANCE AND ALL AAAs ARE NOT TIME BOMBS WAITING TO EXPLODE Location: Trianon Ballroom, 3rd Floor Moderators:TBD
x
1:00 PM - 1:05 PM	Update On A Novel New Technology (Nectero) To Slow AAA Growth; How Does It Work And 3-Year Clinical Results
	Presenter(s):Venkatesh G. Ramaiah, MD Location: Trianon Ballroom, 3rd Floor
1:06 PM - 1:11 PM	Decreasing Frequency Of Elective And Ruptured AAA Repairs Is Due To Epidemiology Rather Than Other Factors Like Screening
	Presenter(s):Ian Loftus, MD / Pete Holt, MD, PhD Location: Trianon Ballroom, 3rd Floor
AAA NECK BEHAVIOR AFTER EVAR
1:12 PM - 1:17 PM	Optimal Stent Design And Optimal Degree Of Oversizing To Avoid Neck Dilatation And Why It Matters
	Presenter(s):Carlos F. Bechara, MD Location: Trianon Ballroom, 3rd Floor
1:18 PM - 1:23 PM	Major Aortic Neck Dilatation Occurs Equally After EVAR And Open Repair: From The DREAM RCT: This ONLY Occurs After EVAR With Self-Expanding Endografts
	Presenter(s):Jan D. Blankensteijn, MD Location: Trianon Ballroom, 3rd Floor
1:24 PM - 1:29 PM	What Should Be The Role OF Physician Modified Endografts (PMEGs) For the Treatment Of Short Or No Neck AAAs When Industry Made F/EVAR Devices Are Available: PMEG Are Only Good In Some Centers
	Presenter(s):Benjamin W. Starnes, MD Location: Trianon Ballroom, 3rd Floor
1:30 PM - 1:35 PM	DEBATE: Low Profile Devices For EVAR Are Failing: Their Future Is Questionable Based On Results Of Other Devices Like The Endurant Endograft At 10 Years (From The ENGAGE OUS Registry)
	Presenter(s):Hence J.M. Verhagen, MD, PhD Location: Trianon Ballroom, 3rd Floor
1:36 PM - 1:41 PM	DEBATE: Not So: Ovation Stent-Grafts (From Endologix) Have Good 5-Year Results With No Neck Dilatation Or Migration Even With Challenging Neck Anatomy: Based On A Multicenter International Study Of A Low Profile Endograft
	Presenter(s):Mahmoud B. Malas, MD, MHS Location: Trianon Ballroom, 3rd Floor
1:42 PM - 1:47 PM	Is AAA Thrombus More Dangerous In Women Than In Men: What Are The Dangers Of Such Thrombus
	Presenter(s):Janet T. Powell, MD, PhD Location: Trianon Ballroom, 3rd Floor
1:48 PM - 1:53 PM	How Well Does Non-Fluoroscopic Guidance Using The IOPS System From Centerline Work For Performance Of Standard EVAR: Findings From The MOTION Trial
	Presenter(s):Francis J. Caputo, MD Location: Trianon Ballroom, 3rd Floor
1:54 PM - 1:59 PM	Despite Great Advances With AAA Management, Little Progress Has Been Made In 2 Important Areas: Improving Indications For Treatment And Precision Of Measurement: AAAs ≤6.0 cm Rarely Rupture
	Presenter(s):Frank J. Criado, MD Location: Trianon Ballroom, 3rd Floor
2:00 PM - 2:06 PM	Panel Discussion
END OF SESSION 43

SESSION 44 SCHEDULE
Wednesday SESSION 44: MORE NEW DEVELOPMENTS IN AAAs: HOW DOES THROMBUS LOAD EFFECT PROGNOSIS AFTER EVAR AND EVAS; OTHER RELATED AAA TOPICS Location: Trianon Ballroom, 3rd Floor Moderators:TBD
x
AAA SAC THROMBUS LOAD
2:06 PM - 2:11 PM	Impact Of Thrombus In AAA Sac And Neck On AAA Behavior And EVAR Outcomes: How To Quantitate Thrombus Load And Distribution
	Presenter(s):Nicos Labropoulos, BSc (Med), PhD, DIC, RVT Location: Trianon Ballroom, 3rd Floor
2:12 PM - 2:17 PM	DEBATE: Large Amount Of AAA Sac Thrombus Promotes Morbidity Without Rupture And With Rupture: By What Mechanisms Is Thrombus Harmful And How Can Thrombus Load Be Quantitated
	Presenter(s):David H. Deaton, MD, FACS Location: Trianon Ballroom, 3rd Floor
2:18 PM - 2:23 PM	DEBATE: Large Flow Luminal Space In An AAA Sac With Minimal Mural Thrombus Is Associated With Adverse Events After EVAR: It Is More Important Than AAA Sac Size: Thrombus May Be Protective
	Presenter(s):Hence J.M. Verhagen, MD, PhD Location: Trianon Ballroom, 3rd Floor
OTHER AAA RELATED TOPICS
2:24 PM - 2:29 PM	Graft Infolding: A Unique EVAR Complication: How To Prevent It And How To Treat It
	Presenter(s):Ashraf Mansour, MD Location: Trianon Ballroom, 3rd Floor
2:30 PM - 2:35 PM	With Aneurysmal Disease What Causes The Aorta To Rotate: What Is The Impact Of Counterclockwise Rotation Of The Aneurysmal Aorta
	Presenter(s):Nicos Labropoulos, BSc (Med), PhD, DIC, RVT Location: Trianon Ballroom, 3rd Floor
2:36 PM - 2:41 PM	Observation For Small AAAs (< 5. 0 cm) Is Safe And Does Not Impair Future EVAR Options
	Presenter(s):Jon S. Matsumura, MD Location: Trianon Ballroom, 3rd Floor
2:42 PM - 2:47 PM	Life Altering Events After Endovascular Aortic Repairs Include Death, Dialysis, Paralysis Or Stroke: The Incidence Of These Events Varies Markedly Depending On The Level Of Repair
	Presenter(s):Marc L. Schermerhorn, MD Location: Trianon Ballroom, 3rd Floor
2:48 PM - 2:53 PM	Update On Technical Tips To Perform SAFE Large Sheath Percutaneous Femoral Access And Closure For Complex AAA EVAR In Obese Or Scarred Groins – Even With Calcified Arteries: It Is Almost Always Possible
	Presenter(s):Barend M.E. Mees, MD, PhD, FEBVS Location: Trianon Ballroom, 3rd Floor
2:54 PM - 2:59 PM	Increased Inflammatory Biomarkers And Increased 18F FDG Uptake On PET CT In AAA Patients Are Associated With Rapid Growth And Worse Long-Term Survival: Should These Markers Be Tested Routinely And How Should AAA Treatment Be Modified If They Are Elevated
	Presenter(s):Natzi Sakalihasan, MD, PhD Location: Trianon Ballroom, 3rd Floor
3:00 PM - 3:06 PM	Panel Discussion
3:06 PM - 3:15 PM	Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 44

SESSION 45 SCHEDULE
Wednesday SESSION 45: HOT AORTIC TOPICS Location: Trianon Ballroom, 3rd Floor Moderators:TBD
x
3:15 PM - 3:20 PM	Aorto-Enteric Fistulas Associated With Infected EVARS Or Open Prosthetic Grafts; What Are The Differences Between Them And What Are the Implications For Treatment
	Presenter(s):Sal Scali, MD Location: Trianon Ballroom, 3rd Floor
3:21 PM - 3:26 PM	Late Delayed Renal Artery Revascularization After Inadvertent Occlusion For Many Days Is Worthwhile: Collaterals Keep The Kidney Viable Although No Urine Is Produced
	Presenter(s):Nikolaos Tsilimparis, MD, PhD Location: Trianon Ballroom, 3rd Floor
3:27 PM - 3:32 PM	Impact Of COVID, The NICE Guidelines And Changing Disease Patterns On AAA Practice In The UK: Which Is Most Important
	Presenter(s):Ian Loftus, MD / Pete Holt, MD, PhD Location: Trianon Ballroom, 3rd Floor
3:33 PM - 3:38 PM	TEVAR For Acute Complicated TBAD: Improved Outcomes When The Endograft Is Extended To Zone 2 Versus Zone 3: Why Is This So And What To Do About The Subclavian Artery
	Presenter(s):Jean M. Panneton, MD Location: Trianon Ballroom, 3rd Floor
3:39 PM - 3:44 PM	Safe Anticoagulation In F/B/EVAR Patients Requiring Spinal Fluid Drainage
	Presenter(s):Afshin Assadian, MD Location: Trianon Ballroom, 3rd Floor
3:45 PM - 3:50 PM	Panel Discussion
3:50 PM - 3:55 PM	Are We Overtreating AAAs: The Current Diameter Threshold For AAA Repair Is No Longer Relevant: Based On New Scrutiny Of Old Trials And A Meta-Analysis Of AAA Rupture Risk
	Presenter(s):Timothy A. Resch, MD, PhD Location: Trianon Ballroom, 3rd Floor
3:56 PM - 4:01 PM	What Is “Failure To Rescue” After Endovascular TAAA Repairs: What Factors Are Responsible And Why Is It Important
	Presenter(s):Jade S. Hiramoto, MD Location: Trianon Ballroom, 3rd Floor
4:02 PM - 4:07 PM	Laser In Situ F/EVAR As An Off-The-Shelf Option For Ruptured Complex Or Short Necked AAAs And Failed EVAR: Experience And Technical Tips
	Presenter(s):Timothy A. Resch, MD, PhD Location: Trianon Ballroom, 3rd Floor
4:08 PM - 4:13 PM	9-Year Experience Shows The Safety And Effectiveness Of Endoanchors For F/EVAR: They Support Shortening Main Endograft Length And Reducing Procedural Complexity
	Presenter(s):Jörg Tessarek, MD Location: Trianon Ballroom, 3rd Floor
4:14 PM - 4:19 PM	Risk Factors And Late Clinical Consequences Of AAA Neck Dilatation After EVAR With Self-Expanding Endografts: What Are The Differences In Neck Behavior After Excluder And Endurant Endografts: Based On 10-Year Results From The ENGAGE Registry
	Presenter(s):Hence J.M. Verhagen, MD, PhD Location: Trianon Ballroom, 3rd Floor
4:20 PM - 4:25 PM	Panel Discussion
END OF SESSION 45

SESSION 46 SCHEDULE
Wednesday SESSION 46: MORE SHORT HOT NEW TOPICS RELATED TO AORTO-ILIAC AND CAROTID DISEASE AND THEIR TREATMENTS Location: Trianon Ballroom, 3rd Floor Moderators:TBD
x
4:26 PM - 4:31 PM	Are Low Profile Devices For EVAR And TEVAR Improving Or Worsening Outcomes
	Presenter(s):Naoki Fujimura, MD, PhD Location: Trianon Ballroom, 3rd Floor
4:32 PM - 4:37 PM	Why Is It Important To Avoid “Lost To Follow Up” In AAA Studies: What Measures Can Do So
	Presenter(s):Matthew W. Mell, MD, MS Location: Trianon Ballroom, 3rd Floor
4:38 PM - 4:43 PM	What Is The VORTEC Technique And How Can It Be used To Avoid Large Artery And Aortic Dissection, Clamping And Suturings
	Presenter(s):Mario L. Lachat, MD / Zoran Rancic, MD, PhD, EMBA HSG Location: Trianon Ballroom, 3rd Floor
4:44 PM - 4:49 PM	Treo Endograft From Terumo Aortic For EVAR: Advantages And Status Of Approval In The US An Japan
	Presenter(s):Matthew J. Eagleton, MD Location: Trianon Ballroom, 3rd Floor
4:50 PM - 4:55 PM	Isolated Iliac Artery Aneurysm Do NOT Rupture And Need To Be Treated Until They Are At Least 4 Centimeters In Diameter
	Presenter(s):Christopher J. Smolock, MD Location: Trianon Ballroom, 3rd Floor
4:56 PM - 5:01 PM	How To Safely Stent The Large Fenestration Of A ZFEN Endograft When It Is Crossed By Struts: Indications For Doing So And Late Results
	Presenter(s):Luis A. Sanchez, MD Location: Trianon Ballroom, 3rd Floor
5:02 PM - 5:07 PM	The Mega-Aortic Syndrome: What Is It: When And How Should Be Treated
	Presenter(s):Martin Czerny, MD Location: Trianon Ballroom, 3rd Floor
5:08 PM - 5:14 PM	Panel Discussion
CAROTID RELATED TOPICS
5:14 PM - 5:19 PM	Transcarotid Artery Revascularization (TCAR) Versus Carotid Endarterectomy (CEA): In A Single Center Experienced In Both, Which Is Best And When
	Presenter(s):Zach AbuRahma, DO / Ali F. AbuRahma, MD Location: Trianon Ballroom, 3rd Floor
5:20 PM - 5:25 PM	Intracranial Angiography During TCAR: Technique And Value
	Presenter(s):Peter L. Faries, MD, FACS / Michael L. Marin, MD Location: Trianon Ballroom, 3rd Floor
MORE AORTA RELATED TOPICS
5:26 PM - 5:31 PM	Improved Survival After Implementation Of A Large Scale Dedicated Network For Aortic Emergencies: Why The French SOS Aorta System Works
	Presenter(s):Jean-Marc Alsac, MD, PhD Location: Trianon Ballroom, 3rd Floor
5:32 PM - 5:37 PM	How Can The Gore Recapturable C3 Excluder Endograft Be Modified As A PMEG For F/EVAR And TAAA Repair: Technique And Results
	Presenter(s):Wayne W. Zhang, MD Location: Trianon Ballroom, 3rd Floor
5:38 PM - 5:43 PM	The Sandwich-Periscope Technique For Left Subclavian Revascularization With Zone 2 TEVAR: It May Be The Best Way And How To Do It: Technique
	Presenter(s):Sukgu Han, MD Location: Trianon Ballroom, 3rd Floor
5:44 PM - 5:49 PM	Role Of Endovascular And Open Treatment For Mid Aortic Syndrome In Children, Teenagers And Young Adults
	Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS Location: Trianon Ballroom, 3rd Floor
5:50 PM - 6:00 PM	Panel Discussion End of Program F
END OF SESSION 46